Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago (2024)

Abstract

In patients with neurodevelopmental disorders (NDDs), exome sequencing (ES), the diagnostic gold standard, reveals an underlying monogenic condition in only approximately 40% of cases. We report the case of a female patient with profound NDD who died 30 years ago at the age of 3 years and for whom genome sequencing (GS) now identified a single-exon deletion in TBCK previously missed by ExomeDepth, the copy number variation (CNV) detection algorithm in ES. Deoxyribonucleic acid (DNA) was extracted from frozen muscle tissue of the index patient and the parents' blood. Genome data were analyzed for structural variants and single nucleotide variants (SUVs)/indels as part of the Bavarian Genomes consortium project. Biallelic variants in TBCK, which are linked to the autosomal recessive disorder TBCK syndrome, were detected in the affected individual: a novel frameshift variant and a deletion of exon 23, previously established as common but underrecognized pathogenic variant in individuals with TBCK syndrome. While in the foregoing ES analysis, calling algorithms for (SNVs)/indels were able to identify the frameshift variant, ExomeDepth failed to call the intragenic deletion. Our case illustrates the added value of GS for the detection of single-exon deletions for which calling from ES data remains challenging and confirms that the deletion of exon 23 in TBCK may be underdiagnosed in patients with NDDs. Furthermore, it shows the importance of molecular or genetic autopsy allowing genetic risk counseling for family members as well as the end of a diagnostic odyssey of 30 years.

Original languageEnglish
JournalNeuropediatrics
DOIs
StateAccepted/In press - 2023
Externally publishedYes

Keywords

  • genome sequencing
  • molecular autopsy
  • neurodevelopmental disorder
  • TBCK

Access to Document

Other files and links

Fingerprint

Dive into the research topics of 'Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago'. Together they form a unique fingerprint.

View full fingerprint

Cite this

  • APA
  • Author
  • BIBTEX
  • Harvard
  • Standard
  • RIS
  • Vancouver

Jacob, M., Brugger, M., Andres, S., Wagner, M., Graf, E., Berutti, R., Tilch, E., Pavlov, M., Mayerhanser, K., Hoefele, J., Meitinger, T., Winkelmann, J., & Brunet, T. (Accepted/In press). Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago. Neuropediatrics. https://doi.org/10.1055/s-0044-1782680

Jacob, Maureen ; Brugger, Melanie ; Andres, Stephanie et al. / Genome Sequencing for Cases Unsolved by Exome Sequencing : Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago. In: Neuropediatrics. 2023.

@article{4c2b7b2ecfb9447b831891ff209c5590,

title = "Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago",

abstract = "In patients with neurodevelopmental disorders (NDDs), exome sequencing (ES), the diagnostic gold standard, reveals an underlying monogenic condition in only approximately 40% of cases. We report the case of a female patient with profound NDD who died 30 years ago at the age of 3 years and for whom genome sequencing (GS) now identified a single-exon deletion in TBCK previously missed by ExomeDepth, the copy number variation (CNV) detection algorithm in ES. Deoxyribonucleic acid (DNA) was extracted from frozen muscle tissue of the index patient and the parents' blood. Genome data were analyzed for structural variants and single nucleotide variants (SUVs)/indels as part of the Bavarian Genomes consortium project. Biallelic variants in TBCK, which are linked to the autosomal recessive disorder TBCK syndrome, were detected in the affected individual: a novel frameshift variant and a deletion of exon 23, previously established as common but underrecognized pathogenic variant in individuals with TBCK syndrome. While in the foregoing ES analysis, calling algorithms for (SNVs)/indels were able to identify the frameshift variant, ExomeDepth failed to call the intragenic deletion. Our case illustrates the added value of GS for the detection of single-exon deletions for which calling from ES data remains challenging and confirms that the deletion of exon 23 in TBCK may be underdiagnosed in patients with NDDs. Furthermore, it shows the importance of molecular or genetic autopsy allowing genetic risk counseling for family members as well as the end of a diagnostic odyssey of 30 years.",

keywords = "genome sequencing, molecular autopsy, neurodevelopmental disorder, TBCK",

author = "Maureen Jacob and Melanie Brugger and Stephanie Andres and Matias Wagner and Elisabeth Graf and Riccardo Berutti and Erik Tilch and Martin Pavlov and Katharina Mayerhanser and Julia Hoefele and Thomas Meitinger and Juliane Winkelmann and Theresa Brunet",

note = "Publisher Copyright: {\textcopyright} 2023 Georg Thieme Verlag. All rights reserved.",

year = "2023",

doi = "10.1055/s-0044-1782680",

language = "English",

journal = "Neuropediatrics",

issn = "0174-304X",

publisher = "Hippokrates Verlag GmbH",

}

Jacob, M, Brugger, M, Andres, S, Wagner, M, Graf, E, Berutti, R, Tilch, E, Pavlov, M, Mayerhanser, K, Hoefele, J, Meitinger, T, Winkelmann, J & Brunet, T 2023, 'Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago', Neuropediatrics. https://doi.org/10.1055/s-0044-1782680

Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago. / Jacob, Maureen; Brugger, Melanie; Andres, Stephanie et al.
In: Neuropediatrics, 2023.

Research output: Contribution to journalArticlepeer-review

TY - JOUR

T1 - Genome Sequencing for Cases Unsolved by Exome Sequencing

T2 - Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago

AU - Jacob, Maureen

AU - Brugger, Melanie

AU - Andres, Stephanie

AU - Wagner, Matias

AU - Graf, Elisabeth

AU - Berutti, Riccardo

AU - Tilch, Erik

AU - Pavlov, Martin

AU - Mayerhanser, Katharina

AU - Hoefele, Julia

AU - Meitinger, Thomas

AU - Winkelmann, Juliane

AU - Brunet, Theresa

N1 - Publisher Copyright:© 2023 Georg Thieme Verlag. All rights reserved.

PY - 2023

Y1 - 2023

N2 - In patients with neurodevelopmental disorders (NDDs), exome sequencing (ES), the diagnostic gold standard, reveals an underlying monogenic condition in only approximately 40% of cases. We report the case of a female patient with profound NDD who died 30 years ago at the age of 3 years and for whom genome sequencing (GS) now identified a single-exon deletion in TBCK previously missed by ExomeDepth, the copy number variation (CNV) detection algorithm in ES. Deoxyribonucleic acid (DNA) was extracted from frozen muscle tissue of the index patient and the parents' blood. Genome data were analyzed for structural variants and single nucleotide variants (SUVs)/indels as part of the Bavarian Genomes consortium project. Biallelic variants in TBCK, which are linked to the autosomal recessive disorder TBCK syndrome, were detected in the affected individual: a novel frameshift variant and a deletion of exon 23, previously established as common but underrecognized pathogenic variant in individuals with TBCK syndrome. While in the foregoing ES analysis, calling algorithms for (SNVs)/indels were able to identify the frameshift variant, ExomeDepth failed to call the intragenic deletion. Our case illustrates the added value of GS for the detection of single-exon deletions for which calling from ES data remains challenging and confirms that the deletion of exon 23 in TBCK may be underdiagnosed in patients with NDDs. Furthermore, it shows the importance of molecular or genetic autopsy allowing genetic risk counseling for family members as well as the end of a diagnostic odyssey of 30 years.

AB - In patients with neurodevelopmental disorders (NDDs), exome sequencing (ES), the diagnostic gold standard, reveals an underlying monogenic condition in only approximately 40% of cases. We report the case of a female patient with profound NDD who died 30 years ago at the age of 3 years and for whom genome sequencing (GS) now identified a single-exon deletion in TBCK previously missed by ExomeDepth, the copy number variation (CNV) detection algorithm in ES. Deoxyribonucleic acid (DNA) was extracted from frozen muscle tissue of the index patient and the parents' blood. Genome data were analyzed for structural variants and single nucleotide variants (SUVs)/indels as part of the Bavarian Genomes consortium project. Biallelic variants in TBCK, which are linked to the autosomal recessive disorder TBCK syndrome, were detected in the affected individual: a novel frameshift variant and a deletion of exon 23, previously established as common but underrecognized pathogenic variant in individuals with TBCK syndrome. While in the foregoing ES analysis, calling algorithms for (SNVs)/indels were able to identify the frameshift variant, ExomeDepth failed to call the intragenic deletion. Our case illustrates the added value of GS for the detection of single-exon deletions for which calling from ES data remains challenging and confirms that the deletion of exon 23 in TBCK may be underdiagnosed in patients with NDDs. Furthermore, it shows the importance of molecular or genetic autopsy allowing genetic risk counseling for family members as well as the end of a diagnostic odyssey of 30 years.

KW - genome sequencing

KW - molecular autopsy

KW - neurodevelopmental disorder

KW - TBCK

UR - http://www.scopus.com/inward/record.url?scp=85189108540&partnerID=8YFLogxK

U2 - 10.1055/s-0044-1782680

DO - 10.1055/s-0044-1782680

M3 - Article

AN - SCOPUS:85189108540

SN - 0174-304X

JO - Neuropediatrics

JF - Neuropediatrics

ER -

Jacob M, Brugger M, Andres S, Wagner M, Graf E, Berutti R et al. Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago. Neuropediatrics. 2023. doi: 10.1055/s-0044-1782680

Genome Sequencing for Cases Unsolved by Exome Sequencing: Identifying a Single-Exon Deletion in TBCK in a Case from 30 Years Ago (2024)

FAQs

Can exome sequencing detect deletion? ›

Designed to detect single nucleotide variants, small insertions or deletions, deletion-insertions (delins), and copy number variants, our WES test provides personalized answers that profoundly impact a patient's medical journey.

What Cannot be detected by exome sequencing? ›

Rare variants at the probe target site may affect analytical sensitivity. Exome sequencing is limited in detecting the following types of mutations (this list might not be exhaustive): large rearrangements. copy number variation mutations (large deletions/duplications)

What type of disease would be identified by exome sequencing? ›

Research has shown that exome sequencing could detect genetic mutations related to birth defects and developmental delays. So, patients who have a family history of disease or are searching for a diagnosis to explain symptoms may be able to avoid unnecessary diagnostic tests by undergoing exome sequencing.

Can whole exome sequencing be wrong? ›

About three out of four patients tested (75 percent) do not receive a diagnosis from WES. WES is not a perfect test. Our current understanding of the human exome is limited.

What can whole exome sequencing miss? ›

WES is not validated for the detection of structural variations (SVs), including copy number variants (CNVs), inversions, and translocations. WES has low sensitivity for structural variations, so detection is limited1.

What is the success rate of exome sequencing? ›

Exome sequencing (ES) has become one of the important diagnostic tools in clinical genetics with a reported diagnostic rate of 25–58%.

Why is genome sequencing better than exome sequencing? ›

One of the major advantages of WGS is that it provides a more comprehensive view of an individual's genetic makeup. WGS can identify variants that are not present in the exome, including those in non-coding regions and structural variants.

How long does it take to get results for whole exome sequencing? ›

Exome sequencing is a highly complex test and requires time for both sequencing and interpreting the information. Most exome results will be available to families within three months.

What is Noonan syndrome? ›

Noonan syndrome is a genetic disorder characterized by short stature, distinctive facial features, heart defects, bleeding problems and skeletal abnormalities. Most individuals with Noonan syndrome have normal intelligence, but some may have special educational needs or intellectual disability.

What diseases are caused by genomic instability? ›

Contents
Table 1. Genomic Instability Syndromes
SyndromeClinical Presentation
Rothmund-Thompson syndromeimmunodeficiency, premature aging, cancer
FA (Fanconi anemia)congenital abnormalities, bone-marrow failure, cancer
XP (Xeroderma pigmentosa)UV light sensitivity, skin aging, skin cancer
6 more rows

What are secondary findings in whole exome sequencing? ›

What are Secondary Findings in Whole Exome Sequencing? A secondary finding is a variation that may contribute to disease but is not the cause of the patient's current condition. Secondary findings are found in up to 5 out of 100 (5%) patients who choose to have WES.

Does 23andme use exome sequencing? ›

Our genotyping product detects 250 health-related variants in our Carrier Status and Genetic Health Risk reports. The Exome Sequencing reports detect 50,000+ hereditary disease-causing variants.

Can genetic testing be incorrect? ›

Rarely, tests results can be false negative, which occur when the results indicate a decreased risk or a genetic condition when the person is actually affected. In some cases, a test result might not give any useful information. This type of result is called uninformative, indeterminate, inconclusive, or ambiguous.

What does whole genome sequencing tell you? ›

Whole genome sequencing reveals the complete DNA make-up of an organism, enabling us to better understand variations both within and between species. This in turn allows us to differentiate between organisms with a precision that other technologies do not allow.

How do you detect gene deletion? ›

Single-gene deletion / duplication testing through comparative genomic hybridization (CGH) is designed to detect relatively small deletions and duplications within a single exon of a given gene or deletions and duplications encompassing the entire gene.

Can whole genome sequencing detect deletions? ›

Whole-genome sequencing can detect single nucleotide variants, insertions/deletions, copy number changes, and large structural variants. Due to recent technological innovations, the latest genome sequencers can perform whole-genome sequencing more efficiently than ever.

What does exome sequencing show? ›

Exome sequencing detects variants in coding exons, with the capability to expand targeted content to include untranslated regions (UTRs) and microRNA for a more comprehensive view of gene regulation. DNA libraries can be prepared in as little as 1 day and require only 4–5 Gb of sequencing per exome.

How do you detect chromosomal deletion? ›

Postnatal diagnosis is suspected by clinical appearance and is confirmed by karyotyping, if the deletion is relatively large, or by other cytogenetic techniques such as fluorescent in situ hybridization or microarray analysis. (See also Overview of Chromosomal Abnormalities.)

Top Articles
Latest Posts
Article information

Author: Catherine Tremblay

Last Updated:

Views: 6077

Rating: 4.7 / 5 (67 voted)

Reviews: 90% of readers found this page helpful

Author information

Name: Catherine Tremblay

Birthday: 1999-09-23

Address: Suite 461 73643 Sherril Loaf, Dickinsonland, AZ 47941-2379

Phone: +2678139151039

Job: International Administration Supervisor

Hobby: Dowsing, Snowboarding, Rowing, Beekeeping, Calligraphy, Shooting, Air sports

Introduction: My name is Catherine Tremblay, I am a precious, perfect, tasty, enthusiastic, inexpensive, vast, kind person who loves writing and wants to share my knowledge and understanding with you.